Abstracts
Showing 852 abstracts.
Citation
Violet Korutaro, Kristin Baltrusaitis, Patricia DeMarrais, Adeodata R Kekitiinwa, Lameck Chinula, Sufia Dadabhai, Maxensia Owor, Mary Glenn Fowler, Patricia Flynn, Louise Kuhn, Kennedy Spann, Lars Bode, Robin Brody, Katherine Luzuriaga, Shahin Lockman, Jennifer Jao, PROMISE study. Maternal Human Milk Immune Profiles Associated with Postnatal HIV Transmission to Infants During Breastfeeding in the PROMISE Study. Presented at: AIDS; 2026 Jul 30; Rio de Janeiro, Brazil.Conference
AIDS
Study
1077BF
Conference Location
Rio de Janeiro, Brazil
Citation
Ashenafi S Cherkos, Sylvia M. LaCourse, Daniel A Enquobahrie, Grace Montepiedra, Caroline Onyango, Blandina T. Mmbaga, Tichaona Vhembo, Gaerolwe Masheto, Gerhard Theron, Adriana Weinberg, Amita Gupta, IMPAACT P1078 TB APPRISE Study team, Barbra A Richardson, Grace John-Stewart. Maternal IPT in pregnancy and growth faltering among HIV-exposed uninfected infants. Presented at: CROI 2022; 2022 Feb 14.Conference
CROI 2022
Study
P1078
Citation
Rhoda S. Sperling, M.D. Maternal Plasma HIV-1 RNA and the Success of Zidovudine (ZDV) in the Prevention of Mother-Child Transmission.Citation
Heather D. Watts, M.D., Rajalaksh Balasubramanian, Sc.D., Robert T. Maupin, Jr., M.D., Issac Delke, M.D., Coleen K. Cunningham, M.D., Alejandro Dorenbaum, M.D., Simone Fiore, M.D., Marie Louise Newell, M.D., Jean-Francois Delfraissy, M.D., Richard D. Gelber, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Mary Culnane, C.R.N.P., M.S., John L. Sullivan, M.D. Maternal Toxicity and Pregnancy Outcome According to Antiretroviral Therapy during Pregnancy. An analysis of the PACTG 316 Study.Citation
A. Tatsoni, Elaine J. Abrams, M.D., Marc Bulterys, M.D., Ph.D., Robert W. Coombs, M.D., Ph.D., James J. Goedert, M.D., Bette T. Korber, M. J. Mayaux, Lynne M. Mofenson, M.D., F.A.A.P., Marie Louise Newell, M.D., Kenneth C. Rich, M.D., David E. Shapiro, Ph.D., J. P. Teglas, Betsy Thompson, J. Weiner, John P.A. Ioannidis, M.D. Maternal viral load and infant disease progression in vertically HIV-1 infected infants: An international meta-analysis. Presented at: 10th Conference on Retroviruses & Opportunistic Infections.Conference
10th Conference on Retroviruses & Opportunistic Infections
Citation
Maturation of glucuronidation; a system specific property.Citation
NH Tobin, A Murphy, F Li, S Brummel, MG Fowler, J McIntyre, JS Currier, T Chipato, P Flynn, B Koos, GM Aldrovandi, PROMISE team. Metabolites, preterm labor and antiretroviral therapy. Presented at: CROI 2020; 2020 Mar 11.Conference
CROI 2020
Study
1077BF
Citation
Methods for Choosing A Cut Point When Dichotomizing A Continuous Response – A Case Study of Predicting Infant Survival with High Resolution Melting Score. Presented at: 89th Int'l Association for Dental Research/40th American Association for Dental Research.Conference
89th Int'l Association for Dental Research/40th American Association for Dental Research
Citation
Methylphenidate Concentrations and Dose Requirements in HIV-infected and Uninfected Children, Adolescents and Young Adults. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.Conference
20th Conference on Retroviruses and Opportunistic Infections
Study
P1080
Citation
Microarray analysis reveals novel insights into immunity to H1N1/09 influenza vaccine in HIV infected children and adolescents in IMPAACT protocol 1088. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.Conference
20th Conference on Retroviruses and Opportunistic Infections
Study
P1088